GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 4901 - 4950 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
6UM6 A0A1W6IPB2 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6UM6 Q2N0S7 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6UM6 6UM6 Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41
6N1W Q2N0S6 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W 6N1W Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6VLR Q2N0S6 BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain
6VLR 6VLR BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain
5VOC Q6SW67 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC Q68674 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC P16837 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC F5HCP3 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC F5HET4 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6SW67 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q68674 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB P16837 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HCP3 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HET4 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5T1D P03231 Crystal structure of EBV gHgL/gp42/E1D1 complex Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain
5T1D P03212 Crystal structure of EBV gHgL/gp42/E1D1 complex Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain
5T1D P0C6Z5 Crystal structure of EBV gHgL/gp42/E1D1 complex Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain
5T1D 5T1D Crystal structure of EBV gHgL/gp42/E1D1 complex Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain
6C5V K9US75 An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain
6C5V Q1HVF6 An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain
6C5V P0C6Z5 An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain
6C5V 6C5V An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain
7LBG Q6SW67 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBG F5HCH8 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBG Q8BCU3 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBG Q03167 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBG 7LBG CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBF Q6SW67 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBF F5HCH8 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBF Q8BCU3 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBF P16234 CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBF 7LBF CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBE Q6SW67 CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain
7LBE F5HCH8 CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024